Cardinal Health profit growth exceeds expectations |
Profit growth comes in well ahead of expectations for the drug distributor's third quarter thanks to repricing of large retail accounts and the renewal of anti-diversion efforts, and the Dublin, Ohio-based company holds fast on full-year earnings projection. • CVS Caremark's first-quarter profit jumps 83% |
| Merck setback on cholesterol drug FDA turns down Cordaptive, but blue-chip drugmaker vows to submit additional data to secure approval. Merck affirms 2008 financial outlook, but shares take a beating. Bristol-Myers Squibb holds firm on 2008 • AstraZeneca plays defense over generics |
MarketWatch Premium Products |
The Technical Indicator Technical analysis for sophisticated traders | Let MarketWatch’s leading industry experts help guide you in optimizing your portfolio’s performance. MarketWatch Premium Products for the self-directed investor, offer research, analysis and actionable ideas to help you reach your investing goals. Get started today! | |
MarketWatch Options Trader The ultimate guide to options trading | ||
Hulbert Financial Digest Get the definitive guide to investment newsletters | ||
HFD Newsletter Profiles In-depth studies of a newsletter's performance | ||
Hulbert Interactive Access the 180-newsletter HFD database | ||
Retirement Weekly Get the retirement you deserve | ||
ETF Trader Profit from exchange-traded funds | ||
Proactive Fund Investor with Bill Donoghue Mutual fund strategies in both bull and bear markets | ||